The goal is to reduce intensity and prevent the "I can't do this" moment that leads to stopping a medication that otherwise could have helped
We need your help to stay independent Nevertheless, GLP-1 agonists like Ozempic are effective in these patients, suggesting that what is measured when we define obesity according to body mass index is not the aspect of overweight that is relevant to insulin resistance (likely because BMI was originally based on white European populations)
Healthcare providers should educate patients about these storage requirements during initial prescribing and reinforce them at follow-up visits
compounded versions have not been reviewed by the FDA
5 Polypharmacy is associated with undesirable outcomes: frailty, cognitive decline, functional decline, falls, fractures, emergency department (ED) visits, hospitalizations, and mortality
With obesity rates climbing and the associated health risks becoming more apparent, the significance of effective weight management solutions cannot be overstated